February 14, 2019
1 min read

Spectralis with OCT2 module installed at International Space Station

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

A Spectralis imaging platform with OCT2 module has been installed at the International Space Station, where it will be used to study space flight associated neuro-ocular syndrome, according to a press release from Heidelberg Engineering.

NASA launched the device on the Antares 230 Cygnus CRS OA-9, also known as Orbital Sciences CRS Flight 9E, from Wallops Island, Virginia, in May. It replaces the Spectralis OCT system that has been operational at the ISS since 2013.

Spectralis with OCT2 module provides scans at 85,000 Hz and enhanced image quality from the vitreous to choroid, the release said.

“We at Heidelberg are particularly proud of the collaboration with NASA to have our imaging technology be part of this mission,” Arianna Schoess Vargas, Heidelberg CEO, said in the release. “With this advanced OCT technology, it is easier for the astronauts to capture high-quality images in even less time. Working in such an environment, there is significant value placed on efficiency that doesn’t compromise quality.”